跳至主要内容
临床试验/TCTR20210702005
TCTR20210702005尚未招募4 期

A split-face, randomized controlled trial of efficacy and tolerability of fractional CO2 laser combined with autologous platelet rich plasma versus fractional CO2 laser alone in the treatment of atrophic acne scars: a pilot study

Astraco Medical Networks Ltd.0 个研究点目标入组 10 人开始时间: 2021年7月2日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • 1. Subjects age 18-50 years old who have symmetrical atrophic acne scars on both sides of the face with mild to severe severity of acne scars.
  • 2. Duration of acne scar from 6 months to 10 years.
  • 3. Subjects are willing to comply with study protocol and sign informed consent.

排除标准

  • 1. Subjects with moderate to severe acne vulgaris (IGA3-4) or currently have active and uncontrolled acne vulgaris.
  • 2. Female subjects who are currently in pregnancy or breastfeeding.
  • 3. Subjects who have rash, infection or other dermatologic diseases on face.
  • 4. Dermatologic procedural treatments within previous 3 months before study enrollment.
  • 5. Subjects with active herpes infection, bleeding diathesis, cancer, HIV or HBV infection.
  • 6. Subjects who have taken isotretinoin within previous 6 months.
  • 7. Subjects who are currently on antiplatelet or anticoagulant drugs.
  • 8. Subjects woth predisposition to keloid formation.
  • 9. Subjects who cannot comply with the study protocol.

研究者

发起方
Astraco Medical Networks Ltd.

相似试验